An­oth­er batch of in­sulin re­called by Vi­a­tris due to a la­bel­ing is­sue

In Jan­u­ary, Vi­a­tris — the com­bi­na­tion of My­lan Phar­ma­ceu­ti­cals and Pfiz­er’s Up­john — was forced to re­call a batch of its Sem­glee in­sulin pens af­ter they were …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER